Fabrication, Characterization and In Vitro Evaluation of Poly(D,L-Lactide-co-Glycolide) Microparticles Loaded With Polyamidoamine-Plasmid DNA Dendriplexes for Applications in Nonviral Gene Delivery

被引:36
作者
Intra, Janjira [1 ]
Salem, Aliasger K. [1 ]
机构
[1] Univ Iowa, Coll Pharm, Div Pharmaceut, Iowa City, IA 52242 USA
基金
美国国家卫生研究院;
关键词
polyamidoamine (PAMAM); poly(D; L-lactide-co-glycolide) (PLGA); nonviral gene delivery; vaccine; plasmid DNA; formulation; dendriplex; microparticle; CONTROLLED-RELEASE; BIODEGRADABLE MICROPARTICLES; CATIONIC MICROPARTICLES; TRANSGENE EXPRESSION; PAMAM DENDRIMERS; MICROSPHERES; NANOPARTICLES; POLYETHYLENIMINE; TRANSFECTION; COMPLEXES;
D O I
10.1002/jps.21840
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report, for the first time, on the preparation, characterization and in vitro testing of poly(D,L-lactide-co-glycolide) (PLGA) microparticles loaded with poly-amidoamine (PAMAM)-plasmid DNA (pDNA) dendriplexes. Loading of pDNA into the PLGA microparticles increased by 150% when pDNA was first complexed with PAMAM dendrimers relative to loading of pDNA alone. Scanning electron microscopy (SEM) showed that the presence of PAMAM dendrimers in the PLGA microparticles created porous features and indentations on the surface of the microparticles. Loading PLGA microparticles with PAMAM-pDNA dendriplexes lowered the average PLGA microparticle size and changed the surface charge of the microparticles from negative to positive when compared to PLGA microparticles loaded with pDNA alone. The zeta-potential and buffering capacity of the microparticles increased as the generation of the PAMAM dendrimer loaded in the PLGA microparticles increased. Gel electrophoresis assays showed that all the PLGA microparticle formulations were able to entrap the pDNA within the PLGA matrix. There was no significant difference in the cytotoxicity of PLGA microparticles loaded with PAMAM-pDNA dendriplexes when compared to PLGA microparticles loaded with pDNA alone. Furthermore, and in contrast to PAMAM dendrimers alone, the generation of the PAMAM dendrimer loaded in the PLGA microparticles had no significant impact on cytotoxicity or transfection efficiencies in human embryonic kidney (HEK293) or Monkey African green kidney fibroblast-like (COS7) cells. The transfection efficiency of PLGA microparticles loaded with generation 3 (G3) PAMAM-pDNA dendriplexes was significantly higher than PLGA microparticles loaded with pDNA alone in HEK293 and COS7 cells. PLGA microparticles loaded with G3 PAMAM-pDNA dendriplexes generated equivalent transfection efficiencies as (G3 to G6) PAMAM-pDNA dendriplexes alone in COS7 cells when the transfection was carried out in serum containing media. The delivery system developed in this report has low toxicity, high pDNA loading efficiencies and high transfection efficiencies that are not reduced in the presence of serum. A delivery system with these characteristics is expected to have significant potential for translational applications. (C) 2009 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 99:368-384, 2010
引用
收藏
页码:368 / 384
页数:17
相关论文
共 58 条
[1]   Formulating poly(lactide-co-glycolide) particles for plasmid DNA delivery [J].
Abbas, Aiman O. ;
Donovan, Maureen D. ;
Salem, Aliasger K. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (07) :2448-2461
[2]   DNA complexing with polyamidoamine dendrimers: Implications for transfection [J].
Bielinska, AU ;
Chen, CL ;
Johnson, J ;
Baker, JR .
BIOCONJUGATE CHEMISTRY, 1999, 10 (05) :843-850
[3]   PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium [J].
Bivas-Benita, M ;
Romeijn, S ;
Junginger, HE ;
Borchard, G .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (01) :1-6
[4]   Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles [J].
Braun, CS ;
Vetro, JA ;
Tomalia, DA ;
Koe, GS ;
Koe, JG ;
Middaugh, CR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (02) :423-436
[5]   Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA [J].
Capan, Y ;
Woo, BH ;
Gebrekidan, S ;
Ahmed, S ;
DeLuca, PP .
PHARMACEUTICAL RESEARCH, 1999, 16 (04) :509-513
[6]   Dendrimers as drug carriers: Applications in different routes of drug administration [J].
Cheng, Yiyun ;
Xu, Zhenhua ;
Ma, Minglu ;
Xu, Tongwen .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (01) :123-143
[7]   PREPARATION OF POROUS AND NONPOROUS BIODEGRADABLE POLYMERIC HOLLOW MICROSPHERES [J].
CROTTS, G ;
PARK, TG .
JOURNAL OF CONTROLLED RELEASE, 1995, 35 (2-3) :91-105
[8]   Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery [J].
Dash, PR ;
Read, ML ;
Barrett, LB ;
Wolfert, M ;
Seymour, LW .
GENE THERAPY, 1999, 6 (04) :643-650
[9]   Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes [J].
De Rosa, G ;
Quaglia, F ;
La Rotonda, MI ;
Appel, M ;
Alphandary, H ;
Fattal, E .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (03) :790-799
[10]   A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/polyethyleneimine solid complexes [J].
De Rosa, G ;
Bochot, A ;
Quaglia, F ;
Besnard, M ;
Fattal, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 254 (01) :89-93